Symmetry Peak Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-7,500
Closed -$555K 116
2023
Q4
$555K Buy
+7,500
New +$492K 0.13% 82
2023
Q1
Sell
-6,200
Closed -$307K 135
2022
Q4
$307K Buy
+6,200
New +$253K 0.15% 73
2021
Q1
Sell
-10,500
Closed -$1.39M 50
2020
Q4
$1.39M Buy
+10,500
New +$1.27M 0.71% 25
2020
Q1
Sell
-10,000
Closed -$925K 45
2019
Q4
$925K Buy
+10,000
New +$879K 0.2% 70
2017
Q2
Sell
-60,000
Closed -$1.42M 161
2017
Q1
$1.42M Buy
+60,000
New +$1.19M 0.21% 53

Other funds holding EXAS

Symmetry Peak Management's EXAS Position: Q1 2023 in Review

Symmetry Peak Management sold out of Exact Sciences (EXAS) in Q1 2023, closing a stake of 5,110 shares — an estimated $253K sold.

Symmetry Peak Management first reported a position in EXAS in Q3 2018 and held it in 4 quarters. The position peaked at $1.66M in Q3 2018. 584 funds tracked by Wall St. Rank hold EXAS as of Q1 2023.

  • Symmetry Peak Management reported no remaining Exact Sciences position as of Q1 2023 after selling out during the quarter.
  • Symmetry Peak Management sold 5,110 Exact Sciences shares in Q1 2023, an estimated $253K.
  • Symmetry Peak Management first reported a position in Exact Sciences in Q3 2018 and held it in 4 quarters.
  • Symmetry Peak Management's Exact Sciences position peaked at $1.66M in Q3 2018.
  • 584 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2023.

Based on Symmetry Peak Management's 13F filing for Q1 2023, filed 15 May 2023.